Hua Zhang
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer. (NCT06617936) | Hua Zhang | 2024-08-27 |
Track Hua Zhang automatically
Every clearance here is in the API, with alerts when new ones post.